After issues at a third-party manufacturer caused the FDA to reject Regeneron's multiple myeloma bispecific antibody ...

Groundbreaking treatment enhances the immune system’s ability to fight cancer Holy Cross Health now offers bispecific therapy, an innovative class of antibody drugs providing new hope for patients ...

In a perspective, Northwestern Engineering’s Chad Mirkin and Milan Mrksich argue that structural precision drives therapeutic ...

Akeso and Summit Therapeutics’ giant-killing, PD-1xVEGF bispecific antibody ivonescimab has posted another phase 3 trial win ...

In the global arena of biomedicine, Guangzhou's innovative drug companies are rewriting the rules with "hard‑core technology.

Having picked up a pipeline of oncology drugs as part of a merger last year, NAYA Biosciences is reverting back to its ...

With this approval, this Columvi combination is a bispecific antibody regimen available for people with DLBCL in Europe whose cancer has returned or for those who did not respond to initial treatment.

With this approval, this Columvi combination is the first bispecific antibody regimen available for people with DLBCL in Europe whose cancer has returned or for those who did not respond to ...

Approval based on Phase III STARGLO study where Columvi in combination with chemotherapy showed a 41% reduction in the risk of death compared to MabThera/Rituxan plus chemotherapy1,2 DLBCL is an ...

Gut Microbiota in Immuno-Oncology: A Practical Guide for Medical Oncologists With a Focus on Antibiotics Stewardship Bispecific antibodies (bsAbs) have emerged as a novel class of therapeutics, ...

AstraZeneca details $2.5B investment in China's political center, funding R&D center, biotech pacts Another red-hot R&D area is bispecific antibodies, a therapeutic class that has become an ...

The rapid progress in bispecific antibody development is underpinned by significant advancements in antibody engineering. US, NY, UNITED STATES, April 9, 2025 /EINPresswire / -- This surge is ...